Idenix Pharmaceuticals, Inc.

Idenix Pharmaceuticals, Inc.

Sector: Commercial Physical And Biological Research Region: MA, United States

Similar to: Advanced Cell Technology, Inc., Medivir AB, Cerep SA

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA.

News & Analysis

You may also be interested in: